Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director · Co-Chief Executive Officer | January 28, 2021 | February 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date January 28, 2021 · Filed February 12, 2021 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2029-12-19 | Direct | 1,250,000 |
Reported balance
After 2021-01-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2021-01-28 · Grant · Acquired 1,250,000 · Balance 1,250,000 F1: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2021 Filed Feb 2, 2021 11:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 90,090 | $0.00 Strike: $53.72 | $0.00 |
DisclosureSEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 8 McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,090 Underlying: Class A Common Stock · 90,090 shares Expires 2026-01-28 F7 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022 Read SEC document |
| January 28, 2021 Filed Feb 2, 2021 11:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 77,700 | $0.00 Strike: $48.17 | $0.00 |
DisclosureSEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 7 McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,700 Underlying: Class A Common Stock · 77,700 shares Expires 2026-01-28 F6 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022 Read SEC document |
| January 28, 2021 Filed Feb 2, 2021 11:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 66,600 | $0.00 Strike: $42.61 | $0.00 |
DisclosureSEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 6 McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,600 Underlying: Class A Common Stock · 66,600 shares Expires 2026-01-28 F5 · derivative.exercise_date: Options vest in three equal annual installments, beginning on January 28, 2022 Read SEC document |
| January 28, 2021 Filed Feb 2, 2021 11:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 416,667 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-21-010449 · tm214849-4_4seq1.xml · derivative · entry 5 McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,667 Underlying: Class A Common Stock · 416,667 shares Expires 2029-12-19 F4 · shares: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares. F4 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares. Read SEC document |
| January 28, 2021 Filed Feb 12, 2021 22:42 UTC Amendment | AdaptHealth Corp. AHCO · Entity 5183 | GrantEmployee Stock Option (right to buy) · Derivative | 1,250,000 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-21-022174 · tm214849-14_4aseq1.xml · derivative · entry 1 McGee Luke · CIK 0001792721 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Class A Common Stock · 1,250,000 shares Expires 2029-12-19 F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person. F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 1,250,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person. Read SEC document |
| January 01, 2021 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 239,793 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 10 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 239,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F5 · price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F5 · derivative.exercise_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F5 · derivative.expiration_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F2 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| January 01, 2021 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 239,793 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · nonDerivative · entry 3 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 666,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). F3 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GiftWarrants · Derivative | 52,384 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 9 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 52,384 shares Expires not disclosed F6 · derivative.exercise_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F6 · derivative.expiration_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GiftWarrants · Derivative | 78,525 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 8 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 78,525 shares Expires not disclosed F6 · derivative.exercise_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F6 · derivative.expiration_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F3 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GiftWarrants · Derivative | 93,212 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 7 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 93,212 shares Expires not disclosed F6 · derivative.exercise_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F6 · derivative.expiration_date: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F2 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · derivative · entry 6 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 239,793 Underlying: Class A Common Stock · 150,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F5 · price: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F5 · derivative.exercise_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F5 · derivative.expiration_date: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). F2 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| December 31, 2020 Filed Jan 6, 2021 01:06 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-001157 · tm211602-1_4seq1.xml · nonDerivative · entry 2 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 427,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). F2 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 1,081,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · derivative · entry 9 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,081,249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F6 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 1,620,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · derivative · entry 8 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,620,815 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass B Common Stock · Derivative | 1,434,171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · derivative · entry 7 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 389,793 Underlying: Class A Common Stock · 1,434,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F4 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 1,081,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · nonDerivative · entry 5 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,168,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). F6 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 1,620,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · nonDerivative · entry 4 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,752,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). F5 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Disposition to issuerClass A Common Stock | 1,312,808 | $29.36 | $38,544,042.88 |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · nonDerivative · entry 3 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 277,151 F3 · shares: Represents the number of shares of Class A Common Stock otherwise issuable upon the exchange of shares of Class B Common Stock of the Issuer (together with the same number of common units of AdaptHealth Holdings LLC) with respect to which the Issuer elected to deliver cash in lieu of shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. F4 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | Exercise / conversionClass A Common Stock | 1,434,171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · nonDerivative · entry 2 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,589,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC). F4 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| May 08, 2020 Filed Dec 10, 2020 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GiftClass B Common Stock · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-133875 · tm2038090-2_4seq1.xml · derivative · entry 6 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,823,964 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed F7 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F7 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F4 · ownership.nature: Securities held directly by 2321 Capital LLC. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 02:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-073990 · a4.xml · nonDerivative · entry 1 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,250 Read SEC document |
| November 21, 2019 Filed Nov 26, 2019 02:30 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-067179 · a4.xml · nonDerivative · entry 1 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,250 Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherWarrants · Derivative | 52,384 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · derivative · entry 10 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 52,384 Underlying: Class A Common Stock · 52,384 shares Expires not disclosed F4 · kind: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F6 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F6 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherWarrants · Derivative | 93,212 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · derivative · entry 9 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 93,212 Underlying: Class A Common Stock · 93,212 shares Expires not disclosed F3 · kind: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F6 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F6 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F3 · ownership.nature: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherWarrants · Derivative | 78,525 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · derivative · entry 8 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 78,525 Underlying: Class A Common Stock · 78,525 shares Expires not disclosed F2 · kind: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F6 · derivative.exercise_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F6 · derivative.expiration_date: The Warrants may be exercised commencing on December 8, 2019; provided that the Issuer has an effective registration statement covering the shares of Class A Common Stock issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Issuer permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the Warrants). The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation. F2 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass B Common Stock · Derivative | 1,081,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · derivative · entry 7 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,081,249 Underlying: Class A Common Stock · 1,081,249 shares Expires not disclosed F5 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass B Common Stock · Derivative | 1,923,964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · derivative · entry 6 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,923,964 Underlying: Class A Common Stock · 1,923,964 shares Expires not disclosed F5 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F3 · ownership.nature: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass B Common Stock · Derivative | 1,620,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · derivative · entry 5 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,620,815 Underlying: Class A Common Stock · 1,620,815 shares Expires not disclosed F5 · derivative.exercise_price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · price: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · derivative.exercise_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F5 · derivative.expiration_date: Securities issued in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof). 319,724 of the common units of AdaptHealth Holdings LLC held directly by 2321 Capital LLC are subject to vesting, with 79,931 units vesting on each of the first four anniversaries of May 20, 2019. F2 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 87,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 4 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 87,551 F4 · kind: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F4 · ownership.nature: Securities held directly by LBM DBE Holdings LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 155,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 3 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 155,788 F3 · kind: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F3 · ownership.nature: Securities held directly by 2321 Capital LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 131,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 2 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 131,241 F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. F2 · ownership.nature: Securities held directly by Fresh Pond Investment LLC. Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 02:21 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 146,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063546 · a4.xml · nonDerivative · entry 1 McGee Luke · CIK 0001792721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,250 F1 · kind: Securities transferred in connection with the closing of the business combination transaction between the issuer and AdaptHealth Holdings LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.